{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:53:22Z","timestamp":1790618002364,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012479","name":"Weston Brain Institute","doi-asserted-by":"publisher","award":["RR191071"],"award-info":[{"award-number":["RR191071"]}],"id":[{"id":"10.13039\/100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012479","name":"Weston Brain Institute","doi-asserted-by":"publisher","award":["RR191071"],"award-info":[{"award-number":["RR191071"]}],"id":[{"id":"10.13039\/100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009307","name":"Parkinson Canada","doi-asserted-by":"publisher","award":["2018-00157"],"award-info":[{"award-number":["2018-00157"]}],"id":[{"id":"10.13039\/501100009307","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009307","name":"Parkinson Canada","doi-asserted-by":"publisher","award":["2018-00157"],"award-info":[{"award-number":["2018-00157"]}],"id":[{"id":"10.13039\/501100009307","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["420504"],"award-info":[{"award-number":["420504"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In Parkinson\u2019s disease (PD) misfolded alpha-synuclein (aSyn) accumulates in the substantia nigra, where dopaminergic neurons are progressively lost. The mechanisms underlying aSyn pathology are still unclear, but they are hypothesized to involve the autophagy-lysosome pathway (ALP). LRRK2 mutations are a major cause of familial and sporadic PD, and LRRK2 kinase activity has been shown to be involved in pS129-aSyn inclusion modulation. We observed selective downregulation of the novel PD risk factor\n                    <jats:italic>RIT2<\/jats:italic>\n                    in vitro and in vivo. Rit2 overexpression in G2019S-LRRK2 cells rescued ALP abnormalities and diminished aSyn inclusions. In vivo, viral mediated overexpression of Rit2 operated neuroprotection against AAV-A53T-aSyn. Furthermore, Rit2 overexpression prevented the A53T-aSyn-dependent increase of LRRK2 kinase activity in vivo. On the other hand, reduction of Rit2 levels leads to defects in the ALP, similar to those induced by the G2019S-LRRK2 mutation. Our data indicate that Rit2 is required for correct lysosome function, inhibits overactive LRRK2 to ameliorate ALP impairment, and counteracts aSyn aggregation and related deficits. Targeting Rit2 could represent an effective strategy to combat neuropathology in familial and idiopathic PD.\n                  <\/jats:p>","DOI":"10.1038\/s41531-023-00484-2","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T07:05:49Z","timestamp":1679900749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The small GTPase Rit2 modulates LRRK2 kinase activity, is required for lysosomal function and protects against alpha-synuclein neuropathology"],"prefix":"10.1038","volume":"9","author":[{"given":"Julia","family":"Obergasteiger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Castonguay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7197-5302","authenticated-orcid":false,"given":"Sara","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0384-7824","authenticated-orcid":false,"given":"Stefano","family":"Magnabosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Frapporti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evy","family":"Lobbestael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Baekelandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6320-0411","authenticated-orcid":false,"given":"Andrew A.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9831-8302","authenticated-orcid":false,"given":"Peter P.","family":"Pramstaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Gravel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1547-3746","authenticated-orcid":false,"given":"Martin","family":"L\u00e9vesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0300-6796","authenticated-orcid":false,"given":"Mattia","family":"Volta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"484_CR1","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"O-B Tysnes","year":"2017","unstructured":"Tysnes, O.-B. & Storstein, A. Epidemiology of Parkinson\u2019s disease. J. Neural Transm. 124, 901\u2013905 (2017).","journal-title":"J. Neural Transm."},{"key":"484_CR2","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Primers 3, 17013 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"484_CR3","doi-asserted-by":"publisher","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","volume":"18","author":"S Lesage","year":"2009","unstructured":"Lesage, S. & Brice, A. Parkinson\u2019s disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 18, R48\u2013R59 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"484_CR4","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer, W. & Przedborski, S. Parkinson\u2019s disease: mechanisms and models. Neuron 39, 889\u2013909 (2003).","journal-title":"Neuron"},{"key":"484_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","volume":"42","author":"H Deng","year":"2018","unstructured":"Deng, H., Wang, P. & Jankovic, J. The genetics of Parkinson disease. Ageing Res. Rev. 42, 72\u201385 (2018).","journal-title":"Ageing Res. Rev."},{"key":"484_CR6","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","volume":"46","author":"DW Dickson","year":"2018","unstructured":"Dickson, D. W. Neuropathology of Parkinson disease. Parkinsonism Relat. Disord. 46, S30\u2013S33 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"484_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert, M., Spillantini, M. G., Del Tredici, K. & Braak, H. 100 years of Lewy pathology. Nat. Rev. Neurol. 9, 13\u201324 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"484_CR8","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon, R. A. The role of autophagy in neurodegenerative disease. Nat. Med. 19, 983\u2013997 (2013).","journal-title":"Nat. Med."},{"key":"484_CR9","first-page":"25","volume":"12","author":"P Anglade","year":"1997","unstructured":"Anglade, P. et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson\u2019s disease. Histol. Histopathol. 12, 25\u201331 (1997).","journal-title":"Histol. Histopathol."},{"key":"484_CR10","doi-asserted-by":"publisher","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","volume":"30","author":"B Dehay","year":"2010","unstructured":"Dehay, B. et al. Pathogenic lysosomal depletion in Parkinson\u2019s disease. J. Neurosci. 30, 12535\u201312544 (2010).","journal-title":"J. Neurosci."},{"key":"484_CR11","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1212\/WNL.0000000000001860","volume":"85","author":"DL Kenney","year":"2015","unstructured":"Kenney, D. L. & Benarroch, E. E. The autophagy-lysosomal pathway: general concepts and clinical implications. Neurology 85, 634\u2013645 (2015).","journal-title":"Neurology"},{"key":"484_CR12","doi-asserted-by":"publisher","unstructured":"Finkbeiner, S. The autophagy lysosomal pathway and neurodegeneration. Cold Spring Harb. Perspect. Biol. 12 https:\/\/doi.org\/10.1101\/cshperspect.a033993 (2020).","DOI":"10.1101\/cshperspect.a033993"},{"key":"484_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/JPD-130192","volume":"3","author":"C Paisan-Ruiz","year":"2013","unstructured":"Paisan-Ruiz, C., Lewis, P. A. & Singleton, A. B. LRRK2: cause, risk, and mechanism. J. Parkinsons Dis. 3, 85\u2013103 (2013).","journal-title":"J. Parkinsons Dis."},{"key":"484_CR14","doi-asserted-by":"publisher","first-page":"273ra215","DOI":"10.1126\/scitranslmed.aaa3634","volume":"7","author":"RN Fuji","year":"2015","unstructured":"Fuji, R. N. et al. Effect of selective LRRK2 kinase inhibition on nonhuman primate lung. Sci. Transl. Med. 7, 273ra215 (2015).","journal-title":"Sci. Transl. Med."},{"key":"484_CR15","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1097\/01.jnen.0000235121.98052.54","volume":"65","author":"J Miklossy","year":"2006","unstructured":"Miklossy, J. et al. LRRK2 expression in normal and pathologic human brain and in human cell lines. J. Neuropathol. Exp. Neurol. 65, 953\u2013963 (2006).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"484_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrneurol.2013.132","volume":"9","author":"J Trinh","year":"2013","unstructured":"Trinh, J. & Farrer, M. Advances in the genetics of Parkinson disease. Nat. Rev. Neurol. 9, 445\u2013454 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"484_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fncel.2014.00301","volume":"8","author":"DA Beccano-Kelly","year":"2014","unstructured":"Beccano-Kelly, D. A. et al. Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice. Front. Cell. Neurosci. 8, 301 (2014).","journal-title":"Front. Cell. Neurosci."},{"key":"484_CR18","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/hmg\/ddu543","volume":"24","author":"DA Beccano-Kelly","year":"2015","unstructured":"Beccano-Kelly, D. A. et al. LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory. Hum. Mol. Genet. 24, 1336\u20131349 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"484_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nn.3636","volume":"17","author":"L Parisiadou","year":"2014","unstructured":"Parisiadou, L. et al. LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. Nat. Neurosci. 17, 367\u2013376 (2014).","journal-title":"Nat. Neurosci."},{"key":"484_CR20","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1523\/JNEUROSCI.3730-10.2011","volume":"31","author":"G Piccoli","year":"2011","unstructured":"Piccoli, G. et al. LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool. J. Neurosci. 31, 2225\u20132237 (2011).","journal-title":"J. Neurosci."},{"key":"484_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.320","volume":"5","author":"S Saez-Atienzar","year":"2014","unstructured":"Saez-Atienzar, S. et al. The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling. Cell Death Dis. 5, e1368 (2014).","journal-title":"Cell Death Dis."},{"key":"484_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-3-319-49969-7_5","volume":"14","author":"C Manzoni","year":"2017","unstructured":"Manzoni, C. & Lewis, P. A. LRRK2 and autophagy. Adv. Neurobiol. 14, 89\u2013105 (2017).","journal-title":"Adv. Neurobiol."},{"key":"484_CR23","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.bbrc.2013.10.159","volume":"441","author":"C Manzoni","year":"2013","unstructured":"Manzoni, C. et al. Pathogenic Parkinson\u2019s disease mutations across the functional domains of LRRK2 alter the autophagic\/lysosomal response to starvation. Biochem. Biophys. Res. Commun. 441, 862\u2013866 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"484_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nbd.2017.12.005","volume":"111","author":"J Schapansky","year":"2018","unstructured":"Schapansky, J. et al. Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble alpha-synuclein in neurons. Neurobiol. Dis. 111, 26\u201335 (2018).","journal-title":"Neurobiol. Dis."},{"key":"484_CR25","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1523\/JNEUROSCI.3642-15.2016","volume":"36","author":"LA Volpicelli-Daley","year":"2016","unstructured":"Volpicelli-Daley, L. A. et al. G2019S-LRRK2 expression augments alpha-synuclein sequestration into inclusions in neurons. J. Neurosci. 36, 7415\u20137427 (2016).","journal-title":"J. Neurosci."},{"key":"484_CR26","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls, M. A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat. Genet. 46, 989\u2013993 (2014).","journal-title":"Nat. Genet."},{"key":"484_CR27","doi-asserted-by":"publisher","unstructured":"Nalls, M. A. et al. Expanding Parkinson\u2019s disease genetics: novel risk loci, genomic context, causal insights and heritable risk. bioRxiv 388165 https:\/\/doi.org\/10.1101\/388165 (2019).","DOI":"10.1101\/388165"},{"key":"484_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ana.22687","volume":"71","author":"N Pankratz","year":"2012","unstructured":"Pankratz, N. et al. Meta-analysis of Parkinson\u2019s disease: identification of a novel locus, RIT2. Ann. Neurol. 71, 370\u2013384 (2012).","journal-title":"Ann. Neurol."},{"key":"484_CR29","doi-asserted-by":"publisher","first-page":"6784","DOI":"10.1523\/JNEUROSCI.16-21-06784.1996","volume":"16","author":"CH Lee","year":"1996","unstructured":"Lee, C. H., Della, N. G., Chew, C. E. & Zack, D. J. Rin, a neuron-specific and calmodulin-binding small G-protein, and Rit define a novel subfamily of ras proteins. J. Neurosci. 16, 6784\u20136794 (1996).","journal-title":"J. Neurosci."},{"key":"484_CR30","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1083\/jcb.200308070","volume":"163","author":"M Hoshino","year":"2003","unstructured":"Hoshino, M. & Nakamura, S. Small GTPase Rin induces neurite outgrowth through Rac\/Cdc42 and calmodulin in PC12 cells. J. Cell Biol. 163, 1067\u20131076 (2003).","journal-title":"J. Cell Biol."},{"key":"484_CR31","doi-asserted-by":"publisher","first-page":"37599","DOI":"10.1074\/jbc.M507364200","volume":"280","author":"GX Shi","year":"2005","unstructured":"Shi, G. X., Han, J. & Andres, D. A. Rin GTPase couples nerve growth factor signaling to p38 and b-Raf\/ERK pathways to promote neuronal differentiation. J. Biol. Chem. 280, 37599\u201337609 (2005).","journal-title":"J. Biol. Chem."},{"key":"484_CR32","doi-asserted-by":"publisher","first-page":"17605","DOI":"10.1074\/jbc.M111400200","volume":"277","author":"ML Spencer","year":"2002","unstructured":"Spencer, M. L., Shao, H., Tucker, H. M. & Andres, D. A. Nerve growth factor-dependent activation of the small GTPase Rin. J. Biol. Chem. 277, 17605\u201317615 (2002).","journal-title":"J. Biol. Chem."},{"key":"484_CR33","doi-asserted-by":"publisher","first-page":"13758","DOI":"10.1523\/JNEUROSCI.2649-11.2011","volume":"31","author":"DM Navaroli","year":"2011","unstructured":"Navaroli, D. M. et al. The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter trafficking. J. Neurosci. 31, 13758\u201313770 (2011).","journal-title":"J. Neurosci."},{"key":"484_CR34","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.1074\/jbc.RA120.012628","volume":"295","author":"RR Fagan","year":"2020","unstructured":"Fagan, R. R. et al. Dopamine transporter trafficking and Rit2 GTPase: mechanism of action and in vivo impact. J. Biol. Chem. 295, 5229\u20135244 (2020).","journal-title":"J. Biol. Chem."},{"key":"484_CR35","doi-asserted-by":"publisher","unstructured":"Sweeney, C. G. et al. Conditional, inducible gene silencing in dopamine neurons reveals a sex-specific role for Rit2 GTPase in acute cocaine response and striatal function. Neuropsychopharmacology https:\/\/doi.org\/10.1038\/s41386-019-0457-x (2019).","DOI":"10.1038\/s41386-019-0457-x"},{"key":"484_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-018-0273-5","volume":"13","author":"J Obergasteiger","year":"2018","unstructured":"Obergasteiger, J., Frapporti, G., Pramstaller, P. P., Hicks, A. A. & Volta, M. A new hypothesis for Parkinson\u2019s disease pathogenesis: GTPase-p38 MAPK signaling and autophagy as convergence points of etiology and genomics. Mol. Neurodegener. 13, 40 (2018).","journal-title":"Mol. Neurodegener."},{"key":"484_CR37","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.2174\/1570159X16666180222165418","volume":"16","author":"Q Rui","year":"2018","unstructured":"Rui, Q., Ni, H., Li, D., Gao, R. & Chen, G. The role of LRRK2 in neurodegeneration of Parkinson disease. Curr. Neuropharmacol. 16, 1348\u20131357 (2018).","journal-title":"Curr. Neuropharmacol."},{"key":"484_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41420-020-0279-y","volume":"6","author":"J Obergasteiger","year":"2020","unstructured":"Obergasteiger, J. et al. Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions. Cell Death Discov. 6, 45 (2020).","journal-title":"Cell Death Discov."},{"key":"484_CR39","doi-asserted-by":"publisher","first-page":"e46199","DOI":"10.1371\/journal.pone.0046199","volume":"7","author":"JC Latourelle","year":"2012","unstructured":"Latourelle, J. C., Dumitriu, A., Hadzi, T. C., Beach, T. G. & Myers, R. H. Evaluation of Parkinson disease risk variants as expression-QTLs. PLoS ONE 7, e46199 (2012).","journal-title":"PLoS ONE"},{"key":"484_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1750-3639.2008.00171.x","volume":"19","author":"K Bossers","year":"2009","unstructured":"Bossers, K. et al. Analysis of gene expression in Parkinson\u2019s disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol. 19, 91\u2013107 (2009).","journal-title":"Brain Pathol."},{"key":"484_CR41","doi-asserted-by":"publisher","first-page":"52ra73","DOI":"10.1126\/scitranslmed.3001059","volume":"2","author":"B Zheng","year":"2010","unstructured":"Zheng, B. et al. PGC-1alpha, a potential therapeutic target for early intervention in Parkinson\u2019s disease. Sci. Transl. Med. 2, 52ra73 (2010).","journal-title":"Sci. Transl. Med."},{"key":"484_CR42","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1371\/journal.pgen.0030098","volume":"3","author":"TG Lesnick","year":"2007","unstructured":"Lesnick, T. G. et al. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet. 3, e98 (2007).","journal-title":"PLoS Genet."},{"key":"484_CR43","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cell.2013.11.009","volume":"155","author":"SD Ryan","year":"2013","unstructured":"Ryan, S. D. et al. Isogenic human iPSC Parkinson\u2019s model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription. Cell 155, 1351\u20131364 (2013).","journal-title":"Cell"},{"key":"484_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.neurobiolaging.2009.02.009","volume":"32","author":"Q Zhou","year":"2011","unstructured":"Zhou, Q., Li, J., Wang, H., Yin, Y. & Zhou, J. Identification of nigral dopaminergic neuron-enriched genes in adult rats. Neurobiol. Aging 32, 313\u2013326 (2011).","journal-title":"Neurobiol. Aging"},{"key":"484_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2010.04.061","volume":"1343","author":"S Phani","year":"2010","unstructured":"Phani, S., Gonye, G. & Iacovitti, L. VTA neurons show a potentially protective transcriptional response to MPTP. Brain Res. 1343, 1\u201313 (2010).","journal-title":"Brain Res."},{"key":"484_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00018-012-1061-y","volume":"70","author":"JM Bravo-San Pedro","year":"2013","unstructured":"Bravo-San Pedro, J. M. et al. The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK\/ERK pathway. Cell Mol. Life Sci. 70, 121\u2013136 (2013).","journal-title":"Cell Mol. Life Sci."},{"key":"484_CR47","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1093\/hmg\/ddu138","volume":"23","author":"J Schapansky","year":"2014","unstructured":"Schapansky, J., Nardozzi, J. D., Felizia, F. & LaVoie, M. J. Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy. Hum. Mol. Genet. 23, 4201\u20134214 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"484_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/mds.27895","volume":"35","author":"G Bellomo","year":"2020","unstructured":"Bellomo, G., Paciotti, S., Gatticchi, L. & Parnetti, L. The vicious cycle between alpha-synuclein aggregation and autophagic-lysosomal dysfunction. Mov. Disord. 35, 34\u201344 (2020).","journal-title":"Mov. Disord."},{"key":"484_CR49","doi-asserted-by":"publisher","unstructured":"Ho, P. W. et al. Age-dependent accumulation of oligomeric SNCA\/alpha-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA). Autophagy 1\u201324 https:\/\/doi.org\/10.1080\/15548627.2019.1603545 (2019).","DOI":"10.1080\/15548627.2019.1603545"},{"key":"484_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","volume":"17","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1). Autophagy 17, 1\u2013382 (2021).","journal-title":"Autophagy"},{"key":"484_CR51","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","volume":"72","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol. 72, 100\u2013105 (2015).","journal-title":"JAMA Neurol."},{"key":"484_CR52","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.parkreldis.2015.07.025","volume":"21","author":"M Volta","year":"2015","unstructured":"Volta, M. et al. Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release. Parkinsonism Relat. Disord. 21, 1156\u20131163 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"484_CR53","doi-asserted-by":"publisher","first-page":"19433","DOI":"10.1074\/jbc.M115.660001","volume":"290","author":"JP Daher","year":"2015","unstructured":"Daher, J. P. et al. Leucine-rich repeat kinase 2 (LRRK2) pharmacological inhibition abates alpha-synuclein gene-induced neurodegeneration. J. Biol. Chem. 290, 19433\u201319444 (2015).","journal-title":"J. Biol. Chem."},{"key":"484_CR54","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.bbrc.2017.06.134","volume":"490","author":"J Obergasteiger","year":"2017","unstructured":"Obergasteiger, J. et al. CADPS2 gene expression is oppositely regulated by LRRK2 and alpha-synuclein. Biochem. Biophys. Res. Commun. 490, 876\u2013881 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"484_CR55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41531-018-0049-1","volume":"4","author":"JH Kluss","year":"2018","unstructured":"Kluss, J. H. et al. Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity. NPJ Parkinsons Dis. 4, 13 (2018).","journal-title":"NPJ Parkinsons Dis."},{"key":"484_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/srep33897","volume":"6","author":"E Lobbestael","year":"2016","unstructured":"Lobbestael, E. et al. Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation. Sci. Rep. 6, 33897 (2016).","journal-title":"Sci. Rep."},{"key":"484_CR57","doi-asserted-by":"publisher","unstructured":"Di Maio, R. et al. LRRK2 activation in idiopathic Parkinson\u2019s disease. Sci. Transl. Med. 10 https:\/\/doi.org\/10.1126\/scitranslmed.aar5429 (2018).","DOI":"10.1126\/scitranslmed.aar5429"},{"key":"484_CR58","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/dvg.20228","volume":"44","author":"CM Backman","year":"2006","unstructured":"Backman, C. M. et al. Characterization of a mouse strain expressing Cre recombinase from the 3\u2019 untranslated region of the dopamine transporter locus. Genesis 44, 383\u2013390 (2006).","journal-title":"Genesis"},{"key":"484_CR59","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1750-1326-8-44","volume":"8","author":"M Oliveras-Salva","year":"2013","unstructured":"Oliveras-Salva, M. et al. rAAV2\/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration. Mol. Neurodegener. 8, 44 (2013).","journal-title":"Mol. Neurodegener."},{"key":"484_CR60","first-page":"3974","volume":"27","author":"T Uenaka","year":"2018","unstructured":"Uenaka, T. et al. In silico drug screening by using genome-wide association study data repurposed dabrafenib, an anti-melanoma drug, for Parkinson\u2019s disease. Hum. Mol. Genet. 27, 3974\u20133985 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"484_CR61","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/aur.1536","volume":"9","author":"X Liu","year":"2016","unstructured":"Liu, X. et al. Genome-wide association study of autism spectrum disorder in the East Asian populations. Autism Res. 9, 340\u2013349 (2016).","journal-title":"Autism Res."},{"key":"484_CR62","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s11011-017-9969-4","volume":"32","author":"SY Hamedani","year":"2017","unstructured":"Hamedani, S. Y. et al. Ras-like without CAAX 2 (RIT2): a susceptibility gene for autism spectrum disorder. Metab. Brain Dis. 32, 751\u2013755 (2017).","journal-title":"Metab. Brain Dis."},{"key":"484_CR63","doi-asserted-by":"publisher","first-page":"10584","DOI":"10.1073\/pnas.1000274107","volume":"107","author":"JT Glessner","year":"2010","unstructured":"Glessner, J. T. et al. Strong synaptic transmission impact by copy number variations in schizophrenia. Proc. Natl. Acad. Sci. USA 107, 10584\u201310589 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"484_CR64","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T. & Sulzer, D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305, 1292\u20131295 (2004).","journal-title":"Science"},{"key":"484_CR65","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nature04723","volume":"441","author":"M Komatsu","year":"2006","unstructured":"Komatsu, M. et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880\u2013884 (2006).","journal-title":"Nature"},{"key":"484_CR66","doi-asserted-by":"publisher","first-page":"a009357","DOI":"10.1101\/cshperspect.a009357","volume":"2","author":"MA Lynch-Day","year":"2012","unstructured":"Lynch-Day, M. A., Mao, K., Wang, K., Zhao, M. & Klionsky, D. J. The role of autophagy in Parkinson\u2019s disease. Cold Spring Harb. Perspect. Med. 2, a009357 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"484_CR67","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.nbd.2009.05.023","volume":"35","author":"Y Chu","year":"2009","unstructured":"Chu, Y., Dodiya, H., Aebischer, P., Olanow, C. W. & Kordower, J. H. Alterations in lysosomal and proteasomal markers in Parkinson\u2019s disease: relationship to alpha-synuclein inclusions. Neurobiol. Dis. 35, 385\u2013398 (2009).","journal-title":"Neurobiol. Dis."},{"key":"484_CR68","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nn.3350","volume":"16","author":"SJ Orenstein","year":"2013","unstructured":"Orenstein, S. J. et al. Interplay of LRRK2 with chaperone-mediated autophagy. Nat. Neurosci. 16, 394\u2013406 (2013).","journal-title":"Nat. Neurosci."},{"key":"484_CR69","doi-asserted-by":"publisher","first-page":"25009","DOI":"10.1074\/jbc.M300227200","volume":"278","author":"JL Webb","year":"2003","unstructured":"Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N. & Rubinsztein, D. C. Alpha-synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278, 25009\u201325013 (2003).","journal-title":"J. Biol. Chem."},{"key":"484_CR70","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1091\/mbc.e07-11-1155","volume":"19","author":"S Kaushik","year":"2008","unstructured":"Kaushik, S., Massey, A. C., Mizushima, N. & Cuervo, A. M. Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy. Mol. Biol. Cell 19, 2179\u20132192 (2008).","journal-title":"Mol. Biol. Cell"},{"key":"484_CR71","doi-asserted-by":"publisher","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West, A. B. et al. Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl. Acad. Sci. USA 102, 16842\u201316847 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"484_CR72","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.omtn.2017.08.002","volume":"8","author":"HT Zhao","year":"2017","unstructured":"Zhao, H. T. et al. LRRK2 antisense oligonucleotides ameliorate alpha-synuclein inclusion formation in a Parkinson\u2019s disease mouse model. Mol. Ther. Nucleic Acids 8, 508\u2013519 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"484_CR73","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1042\/BJ20100784","volume":"430","author":"N Dzamko","year":"2010","unstructured":"Dzamko, N. et al. Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)\/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization. Biochem. J. 430, 405\u2013413 (2010).","journal-title":"Biochem. J."},{"key":"484_CR74","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20100483","volume":"430","author":"RJ Nichols","year":"2010","unstructured":"Nichols, R. J. et al. 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson\u2019s disease-associated mutations and regulates cytoplasmic localization. Biochem. J. 430, 393\u2013404 (2010).","journal-title":"Biochem. J."},{"key":"484_CR75","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1093\/hmg\/ddr348","volume":"20","author":"MC Herzig","year":"2011","unstructured":"Herzig, M. C. et al. LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice. Hum. Mol. Genet. 20, 4209\u20134223 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"484_CR76","doi-asserted-by":"publisher","first-page":"e00484","DOI":"10.1002\/prp2.484","volume":"7","author":"D Mercatelli","year":"2019","unstructured":"Mercatelli, D. et al. Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes. Pharmacol. Res. Perspect. 7, e00484 (2019).","journal-title":"Pharmacol. Res. Perspect."},{"key":"484_CR77","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1002\/mds.26686","volume":"31","author":"KB Fraser","year":"2016","unstructured":"Fraser, K. B. et al. Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson\u2019s disease. Mov. Disord. 31, 1543\u20131550 (2016).","journal-title":"Mov. Disord."},{"key":"484_CR78","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1523\/JNEUROSCI.1931-17.2018","volume":"38","author":"D Leo","year":"2018","unstructured":"Leo, D. et al. Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats. J. Neurosci. 38, 1959\u20131972 (2018).","journal-title":"J. Neurosci."},{"key":"484_CR79","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.bbrc.2015.07.007","volume":"464","author":"J Lu","year":"2015","unstructured":"Lu, J., Sun, F., Ma, H., Qing, H. & Deng, Y. Comparison between \u03b1-synuclein wild-type and A53T mutation in a progressive Parkinson\u2019s disease model. Biochem. Biophys. Res. Commun. 464, 988\u2013993 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"484_CR80","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ng.485","volume":"41","author":"W Satake","year":"2009","unstructured":"Satake, W. et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease. Nat. Genet. 41, 1303\u20131307 (2009).","journal-title":"Nat. Genet."},{"key":"484_CR81","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3389\/fnmol.2018.00417","volume":"11","author":"J Madero-Perez","year":"2018","unstructured":"Madero-Perez, J. et al. RAB7L1-mediated relocalization of LRRK2 to the Golgi complex causes centrosomal deficits via RAB8A. Front. Mol. Neurosci. 11, 417 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"484_CR82","doi-asserted-by":"publisher","first-page":"E9115","DOI":"10.1073\/pnas.1812196115","volume":"115","author":"T Eguchi","year":"2018","unstructured":"Eguchi, T. et al. LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis. Proc. Natl. Acad. Sci. USA 115, E9115\u2013E9124 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"484_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embj.201798099","volume":"37","author":"E Purlyte","year":"2018","unstructured":"Purlyte, E. et al. Rab29 activation of the Parkinson\u2019s disease-associated LRRK2 kinase. EMBO J. 37, 1\u201318 (2018).","journal-title":"EMBO J."},{"key":"484_CR84","doi-asserted-by":"publisher","first-page":"e96242","DOI":"10.1371\/journal.pone.0096242","volume":"9","author":"S Wang","year":"2014","unstructured":"Wang, S. et al. A role of Rab29 in the integrity of the trans-Golgi network and retrograde trafficking of mannose-6-phosphate receptor. PLoS ONE 9, e96242 (2014).","journal-title":"PLoS ONE"},{"key":"484_CR85","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00438-017-1294-4","volume":"292","author":"B Emamalizadeh","year":"2017","unstructured":"Emamalizadeh, B. et al. The human RIT2 core promoter short tandem repeat predominant allele is species-specific in length: a selective advantage for human evolution? Mol. Genet. Genom. 292, 611\u2013617 (2017).","journal-title":"Mol. Genet. Genom."},{"key":"484_CR86","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnmol.2014.00051","volume":"7","author":"R Vancraenenbroeck","year":"2014","unstructured":"Vancraenenbroeck, R. et al. In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2. Front. Mol. Neurosci. 7, 51 (2014).","journal-title":"Front. Mol. Neurosci."},{"key":"484_CR87","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cellsig.2016.11.012","volume":"30","author":"M Volta","year":"2017","unstructured":"Volta, M. et al. Elevated levels of alpha-synuclein blunt cellular signal transduction downstream of Gq protein-coupled receptors. Cell. Signal. 30, 82\u201391 (2017).","journal-title":"Cell. Signal."},{"key":"484_CR88","doi-asserted-by":"publisher","first-page":"E4387","DOI":"10.1073\/pnas.1520387113","volume":"113","author":"H Doucet-Beaupr\u00e9","year":"2016","unstructured":"Doucet-Beaupr\u00e9, H. et al. Lmx1a and Lmx1b regulate mitochondrial functions and survival of adult midbrain dopaminergic neurons. Proc. Natl. Acad. Sci. USA 113, E4387\u2013E4396 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00484-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00484-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00484-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T08:10:16Z","timestamp":1679904616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00484-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["484"],"URL":"https:\/\/doi.org\/10.1038\/s41531-023-00484-2","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"assertion":[{"value":"2 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}